Goodbye Diabetes

Goodbye Diabetes

Towards the Development of a Cure for Diabetes.

We are conducting research aimed at curing diseases,
rather than merely managing them with symptomatic treatments.

Towards the Development of a Cure for Diabetes.

News

Vision For the Future

We aim to cure diseases with “a therapeutic drug that cures diabetes” and “cell-targeting technology,” which delivers drugs to specific cells, moving beyond mere symptomatic treatment.

We aim to cure diseases with “a therapeutic drug that cures diabetes” and “cell-targeting technology,” which delivers drugs to specific cells, moving beyond mere symptomatic treatment.

Company Information

Biozipcode, Inc. is committed to assisting pharmaceutical and health food manufacturers, as well as research institutions interested in diabetes treatment and regenerative medicine, with their product development and research endeavors.

Research Members

We are engaged in developing a cure for diabetes and in our cell-targeting technology (Biozipcode) project, centered around Dr.Hideto Kojima, a special professor in the Regenerative Medicine Development Course established at Shiga University of Medical Science.

Our Business

Biozipcode, Inc. is advancing the development of a therapeutic drug that cures diabetes, a disease often deemed incurable.

We are raising funds, recruiting talent, and building cooperative relationships with external partners.

Contact Us

Please feel free to fill in the necessary information in the form below and contact us at your convenience.